Pre-pectoral Breast Reconstruction With or Without Mesh
Recruiting now · Not applicable
Conditions studied: Prepectoral Breast Reconstruction, TiLOOP Mesh
In brief
To explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that when TiLOOP Mesh is not used.
Key facts
- Study ID
- NCT05888571
- Run by
- Tianjin Medical University Cancer Institute and Hospital
- People needed
- 164
- Starts
- 2023-07-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2024-01-31
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Adult women aged 18-65 years who plan to undergo unilateral or bilateral immediate prepectoral prothesis breast reconstruction;
- SSM or NSM or Skin-Reducing Mastectomy for breast cancer patients or prophylactic mastectomy;
- Tissue expander size =<800cc, implant size =<600cc;
- The blood perfusion of breast skin flap was well;
- Do not smoking in the last 4 weeks or more
- Patients with normal expectations and mental health for breast reconstruction;
- Signed consent to participate
You may not qualify if…
- Poor perfusion of breast mastectomy flap;
- II stage breast reconstruction patients;
- History of chest radiotherapy;
- BMI greater than 35;
- Patients who have not quit smoking within the last 4 weeks;
Where it is running
- Tianjin Medical University Cancer Institute and Hospital — Tianjin, Tianjin Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.